Try a new search

Format these results:

Searched for:

school:SOM

Department/Unit:Child and Adolescent Psychiatry

Total Results:

11211


Real-time processes in the development of action planning

Ossmy, Ori; Kaplan, Brianna E; Han, Danyang; Xu, Melody; Bianco, Catherine; Mukamel, Roy; Adolph, Karen E
Across species and ages, planning multi-step actions is a hallmark of intelligence and critical for survival. Traditionally, researchers adopt a "top-down" approach to action planning by focusing on the ability to create an internal representation of the world that guides the next step in a multi-step action. However, a top-down approach does not inform on underlying mechanisms, so researchers can only speculate about how and why improvements in planning occur. The current study takes a "bottom-up" approach by testing developmental changes in the real-time, moment-to-moment interplay among perceptual, neural, and motor components of action planning using simultaneous video, motion-tracking, head-mounted eye tracking, and electroencephalography (EEG). Preschoolers (n = 32) and adults (n = 22) grasped a hammer with their dominant hand to pound a peg when the hammer handle pointed in different directions. When the handle pointed toward their non-dominant hand, younger children ("nonadaptive planners") used a habitual overhand grip that interfered with wielding the hammer, whereas adults and older children ("adaptive planners") used an adaptive underhand grip. Adaptive and nonadaptive children differed in when and where they directed their gaze to obtain visual information, neural activation of the motor system before reaching, and straightness of their reach trajectories. Nonadaptive children immediately used a habitual overhand grip before gathering visual information, leaving insufficient time to form a plan before acting. Our novel bottom-up approach transcends mere speculation by providing converging evidence that the development of action planning depends on a real-time "tug of war" between habits and information gathering and processing.
PMID: 34883048
ISSN: 1879-0445
CID: 5457112

Toward next-generation primate neuroscience: A collaboration-based strategic plan for integrative neuroimaging

Milham, Michael; Petkov, Chris; Belin, Pascal; Ben Hamed, Suliann; Evrard, Henry; Fair, Damien; Fox, Andrew; Froudist-Walsh, Sean; Hayashi, Takuya; Kastner, Sabine; Klink, Chris; Majka, Piotr; Mars, Rogier; Messinger, Adam; Poirier, Colline; Schroeder, Charles; Shmuel, Amir; Silva, Afonso C; Vanduffel, Wim; Van Essen, David C; Wang, Zheng; Roe, Anna Wang; Wilke, Melanie; Xu, Ting; Aarabi, Mohammad Hadi; Adolphs, Ralph; Ahuja, Aarit; Alvand, Ashkan; Amiez, Celine; Autio, Joonas; Azadi, Reza; Baeg, Eunha; Bai, Ruiliang; Bao, Pinglei; Basso, Michele; Behel, Austin K; Bennett, Yvonne; Bernhardt, Boris; Biswal, Bharat; Boopathy, Sethu; Boretius, Susann; Borra, Elena; Boshra, Rober; Buffalo, Elizabeth; Cao, Long; Cavanaugh, James; Celine, Amiez; Chavez, Gianfranco; Chen, Li Min; Chen, Xiaodong; Cheng, Luqi; Chouinard-Decorte, Francois; Clavagnier, Simon; Cléry, Justine; Colcombe, Stan J; Conway, Bevil; Cordeau, Melina; Coulon, Olivier; Cui, Yue; Dadarwal, Rakshit; Dahnke, Robert; Desrochers, Theresa; Deying, Li; Dougherty, Kacie; Doyle, Hannah; Drzewiecki, Carly M; Duyck, Marianne; Arachchi, Wasana Ediri; Elorette, Catherine; Essamlali, Abdelhadi; Evans, Alan; Fajardo, Alfonso; Figueroa, Hector; Franco, Alexandre; Freches, Guilherme; Frey, Steve; Friedrich, Patrick; Fujimoto, Atsushi; Fukunaga, Masaki; Gacoin, Maeva; Gallardo, Guillermo; Gao, Lixia; Gao, Yang; Garside, Danny; Garza-Villarreal, Eduardo A; Gaudet-Trafit, Maxime; Gerbella, Marzio; Giavasis, Steven; Glen, Daniel; Ribeiro Gomes, Ana Rita; Torrecilla, Sandra Gonzalez; Gozzi, Alessandro; Gulli, Roberto; Haber, Suzanne; Hadj-Bouziane, Fadila; Fujimoto, Satoka Hashimoto; Hawrylycz, Michael; He, Quansheng; He, Ye; Heuer, Katja; Hiba, Bassem; Hoffstaedter, Felix; Hong, Seok-Jun; Hori, Yuki; Hou, Yujie; Howard, Amy; de la Iglesia-Vaya, Maria; Ikeda, Takuro; Jankovic-Rapan, Lucija; Jaramillo, Jorge; Jedema, Hank P; Jin, Hecheng; Jiang, Minqing; Jung, Benjamin; Kagan, Igor; Kahn, Itamar; Kiar, Gregory; Kikuchi, Yuki; Kilavik, Bjørg; Kimura, Nobuyuki; Klatzmann, Ulysse; Kwok, Sze Chai; Lai, Hsin-Yi; Lamberton, Franck; Lehman, Julia; Li, Pengcheng; Li, Xinhui; Li, Xinjian; Liang, Zhifeng; Liston, Conor; Little, Roger; Liu, Cirong; Liu, Ning; Liu, Xiaojin; Liu, Xinyu; Lu, Haidong; Loh, Kep Kee; Madan, Christopher; Magrou, Loïc; Margulies, Daniel; Mathilda, Froesel; Mejia, Sheyla; Meng, Yao; Menon, Ravi; Meunier, David; Mitchell, A J; Mitchell, Anna; Murphy, Aidan; Mvula, Towela; Ortiz-Rios, Michael; Ortuzar Martinez, Diego Emanuel; Pagani, Marco; Palomero-Gallagher, Nicola; Pareek, Vikas; Perkins, Pierce; Ponce, Fernanda; Postans, Mark; Pouget, Pierre; Qian, Meizhen; Ramirez, Julian Bene; Raven, Erika; Restrepo, Isabel; Rima, Samy; Rockland, Kathleen; Rodriguez, Nadira Yusif; Roger, Elise; Hortelano, Eduardo Rojas; Rosa, Marcello; Rossi, Andrew; Rudebeck, Peter; Russ, Brian; Sakai, Tomoko; Saleem, Kadharbatcha S; Sallet, Jerome; Sawiak, Stephen; Schaeffer, David; Schwiedrzik, Caspar M; Seidlitz, Jakob; Sein, Julien; Sharma, Jitendra; Shen, Kelly; Sheng, Wei-An; Shi, Neo Sunhang; Shim, Won Mok; Simone, Luciano; Sirmpilatze, Nikoloz; Sivan, Virginie; Song, Xiaowei; Tanenbaum, Aaron; Tasserie, Jordy; Taylor, Paul; Tian, Xiaoguang; Toro, Roberto; Trambaiolli, Lucas; Upright, Nick; Vezoli, Julien; Vickery, Sam; Villalon, Julio; Wang, Xiaojie; Wang, Yufan; Weiss, Alison R; Wilson, Charlie; Wong, Ting-Yat; Woo, Choong-Wan; Wu, Bichan; Xiao, Du; Xu, Augix Guohua; Xu, Dongrong; Xufeng, Zhou; Yacoub, Essa; Ye, Ningrong; Ying, Zhang; Yokoyama, Chihiro; Yu, Xiongjie; Yue, Shasha; Yuheng, Lu; Yumeng, Xin; Zaldivar, Daniel; Zhang, Shaomin; Zhao, Yuguang; Zuo, Zhanguang
Open science initiatives are creating opportunities to increase research coordination and impact in nonhuman primate (NHP) imaging. The PRIMatE Data and Resource Exchange community recently developed a collaboration-based strategic plan to advance NHP imaging as an integrative approach for multiscale neuroscience.
PMID: 34731649
ISSN: 1097-4199
CID: 5499342

Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma

Park, Hyung; Tarpey, Thaddeus; Liu, Mengling; Goldfeld, Keith; Wu, Yinxiang; Wu, Danni; Li, Yi; Zhang, Jinchun; Ganguly, Dipyaman; Ray, Yogiraj; Paul, Shekhar Ranjan; Bhattacharya, Prasun; Belov, Artur; Huang, Yin; Villa, Carlos; Forshee, Richard; Verdun, Nicole C; Yoon, Hyun Ah; Agarwal, Anup; Simonovich, Ventura Alejandro; Scibona, Paula; Burgos Pratx, Leandro; Belloso, Waldo; Avendaño-Solá, Cristina; Bar, Katharine J; Duarte, Rafael F; Hsue, Priscilla Y; Luetkemeyer, Anne F; Meyfroidt, Geert; Nicola, André M; Mukherjee, Aparna; Ortigoza, Mila B; Pirofski, Liise-Anne; Rijnders, Bart J A; Troxel, Andrea; Antman, Elliott M; Petkova, Eva
Importance:Identifying which patients with COVID-19 are likely to benefit from COVID-19 convalescent plasma (CCP) treatment may have a large public health impact. Objective:To develop an index for predicting the expected relative treatment benefit from CCP compared with treatment without CCP for patients hospitalized for COVID-19 using patients' baseline characteristics. Design, Setting, and Participants:This prognostic study used data from the COMPILE study, ie, a meta-analysis of pooled individual patient data from 8 randomized clinical trials (RCTs) evaluating CCP vs control in adults hospitalized for COVID-19 who were not receiving mechanical ventilation at randomization. A combination of baseline characteristics, termed the treatment benefit index (TBI), was developed based on 2287 patients in COMPILE using a proportional odds model, with baseline characteristics selected via cross-validation. The TBI was externally validated on 4 external data sets: the Expanded Access Program (1896 participants), a study conducted under Emergency Use Authorization (210 participants), and 2 RCTs (with 80 and 309 participants). Exposure:Receipt of CCP. Main Outcomes and Measures:World Health Organization (WHO) 11-point ordinal COVID-19 clinical status scale and 2 derivatives of it (ie, WHO score of 7-10, indicating mechanical ventilation to death, and WHO score of 10, indicating death) at day 14 and day 28 after randomization. Day 14 WHO 11-point ordinal scale was used as the primary outcome to develop the TBI. Results:A total of 2287 patients were included in the derivation cohort, with a mean (SD) age of 60.3 (15.2) years and 815 (35.6%) women. The TBI provided a continuous gradation of benefit, and, for clinical utility, it was operationalized into groups of expected large clinical benefit (B1; 629 participants in the derivation cohort [27.5%]), moderate benefit (B2; 953 [41.7%]), and potential harm or no benefit (B3; 705 [30.8%]). Patients with preexisting conditions (diabetes, cardiovascular and pulmonary diseases), with blood type A or AB, and at an early COVID-19 stage (low baseline WHO scores) were expected to benefit most, while those without preexisting conditions and at more advanced stages of COVID-19 could potentially be harmed. In the derivation cohort, odds ratios for worse outcome, where smaller odds ratios indicate larger benefit from CCP, were 0.69 (95% credible interval [CrI], 0.48-1.06) for B1, 0.82 (95% CrI, 0.61-1.11) for B2, and 1.58 (95% CrI, 1.14-2.17) for B3. Testing on 4 external datasets supported the validation of the derived TBIs. Conclusions and Relevance:The findings of this study suggest that the CCP TBI is a simple tool that can quantify the relative benefit from CCP treatment for an individual patient hospitalized with COVID-19 that can be used to guide treatment recommendations. The TBI precision medicine approach could be especially helpful in a pandemic.
PMCID:8790670
PMID: 35076698
ISSN: 2574-3805
CID: 5153212

Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysis

Troxel, Andrea B; Petkova, Eva; Goldfeld, Keith; Liu, Mengling; Tarpey, Thaddeus; Wu, Yinxiang; Wu, Danni; Agarwal, Anup; Avendaño-Solá, Cristina; Bainbridge, Emma; Bar, Katherine J; Devos, Timothy; Duarte, Rafael F; Gharbharan, Arvind; Hsue, Priscilla Y; Kumar, Gunjan; Luetkemeyer, Annie F; Meyfroidt, Geert; Nicola, André M; Mukherjee, Aparna; Ortigoza, Mila B; Pirofski, Liise-Anne; Rijnders, Bart J A; Rokx, Casper; Sancho-Lopez, Arantxa; Shaw, Pamela; Tebas, Pablo; Yoon, Hyun-Ah; Grudzen, Corita; Hochman, Judith; Antman, Elliott M
Importance:COVID-19 convalescent plasma (CCP) is a potentially beneficial treatment for COVID-19 that requires rigorous testing. Objective:To compile individual patient data from randomized clinical trials of CCP and to monitor the data until completion or until accumulated evidence enables reliable conclusions regarding the clinical outcomes associated with CCP. Data Sources:From May to August 2020, a systematic search was performed for trials of CCP in the literature, clinical trial registry sites, and medRxiv. Domain experts at local, national, and international organizations were consulted regularly. Study Selection:Eligible trials enrolled hospitalized patients with confirmed COVID-19, not receiving mechanical ventilation, and randomized them to CCP or control. The administered CCP was required to have measurable antibodies assessed locally. Data Extraction and Synthesis:A minimal data set was submitted regularly via a secure portal, analyzed using a prespecified bayesian statistical plan, and reviewed frequently by a collective data and safety monitoring board. Main Outcomes and Measures:Prespecified coprimary end points-the World Health Organization (WHO) 11-point ordinal scale analyzed using a proportional odds model and a binary indicator of WHO score of 7 or higher capturing the most severe outcomes including mechanical ventilation through death and analyzed using a logistic model-were assessed clinically at 14 days after randomization. Results:Eight international trials collectively enrolled 2369 participants (1138 randomized to control and 1231 randomized to CCP). A total of 2341 participants (median [IQR] age, 60 [50-72] years; 845 women [35.7%]) had primary outcome data as of April 2021. The median (IQR) of the ordinal WHO scale was 3 (3-6); the cumulative OR was 0.94 (95% credible interval [CrI], 0.74-1.19; posterior probability of OR <1 of 71%). A total of 352 patients (15%) had WHO score greater than or equal to 7; the OR was 0.94 (95% CrI, 0.69-1.30; posterior probability of OR <1 of 65%). Adjusted for baseline covariates, the ORs for mortality were 0.88 at day 14 (95% CrI, 0.61-1.26; posterior probability of OR <1 of 77%) and 0.85 at day 28 (95% CrI, 0.62-1.18; posterior probability of OR <1 of 84%). Heterogeneity of treatment effect sizes was observed across an array of baseline characteristics. Conclusions and Relevance:This meta-analysis found no association of CCP with better clinical outcomes for the typical patient. These findings suggest that real-time individual patient data pooling and meta-analysis during a pandemic are feasible, offering a model for future research and providing a rich data resource.
PMCID:8790669
PMID: 35076699
ISSN: 2574-3805
CID: 5153222

The feasibility of a strategy for the remote recruitment, consenting and assessment of recent referrals: a protocol for phase 1 of the On-Line Parent Training for the Initial Management of ADHD referrals (OPTIMA)

Kostyrka-Allchorne, Katarzyna; Ballard, Claire; Byford, Sarah; Cortese, Samuele; Daley, David; Downs, Johnny; French, Blandine; Glazebrook, Cristine; Goldsmith, Kimberley; Groom, Madeleine J; Hall, Charlotte L; Hedstrom, Ellen; Ibrahim, Zina; Jarvis, Christine; Kovshoff, Hanna; Kreppner, Jana; Lean, Nancy; Morris, Anna; Gutierrez, Walter Muruet; Sayal, Kapil; Shearer, James; Simonoff, Emily; Thompson, Margaret; Zalewski, Lukasz; Sonuga-Barke, Edmund J S
BACKGROUND:In the UK, children with high levels of hyperactivity, impulsivity and inattention referred to clinical services with possible attention-deficit/hyperactivity disorder (ADHD) often wait a long time for specialist diagnostic assessment. Parent training (PT) has the potential to support parents during this difficult period, especially regarding the management of challenging and disruptive behaviours that often accompany ADHD. However, traditional face-to-face PT is costly and difficult to organise in a timely way. We have created a low-cost, easily accessible PT programme delivered via a phone app, Structured E-Parenting Support (STEPS), to address this problem. The overall OPTIMA programme will evaluate the efficacy and cost-effectiveness of STEPS as a way of helping parents manage their children behaviour while on the waitlist. To ensure the timely and efficient evaluation of STEPS in OPTIMA, we have worked with children's health services to implement a remote strategy for recruitment, screening and assessment of recently referred families. Part of this strategy is incorporated into routine clinical practice and part is OPTIMA specific. Here, we present the protocol for Phase 1 of OPTIMA-a study of the feasibility of this remote strategy, as a basis for a large-scale STEPS randomised controlled trial (RCT). METHODS:This is a single arm observational feasibility study. Participants will be parents of up to 100 children aged 5-11 years with high levels of hyperactivity/impulsivity, inattention and challenging behaviour who are waiting for assessment in one of five UK child and adolescent mental health or behavioural services. Recruitment, consenting and data collection will occur remotely. The primary outcome will be the rate at which the families, who meet inclusion criteria, agree in principle to take part in a full STEPS RCT. Secondary outcomes include acceptability of remote consenting and online data collection procedures; the feasibility of collecting teacher data remotely within the required timeframe, and technical difficulties with completing online questionnaires. All parents in the study will receive access to STEPS. DISCUSSION/CONCLUSIONS:Establishing the feasibility of our remote recruitment, consenting and assessment strategy is a pre-requisite for the full trial of OPTIMA. It can also provide a model for future trials conducted remotely.
PMCID:8720938
PMID: 34980279
ISSN: 2055-5784
CID: 5106902

Behavioral Activation as a Principle-Based Treatment: Developments from a Multi-Site Collaboration to Advance Adolescent Depression Treatment

Jenness, Jessica L.; DeLonga, Kathryn; Lewandowski, R. Eric; Spiro, Carolyn; Crowe, Katherine; Martell, Christopher R.; Towbin, Kenneth E.; Stringaris, Argyris; McCauley, Elizabeth
Adolescent depression is a serious and debilitating disorder associated with lifelong negative outcomes, including heightened risk for recurrence into adulthood, psychiatric comorbidities, and suicide. Among evidence-based treatments for adolescents, psychotherapies for depression have the smallest effect sizes of all psychiatric conditions studied. Advancing care for depression in adolescents is complex due to the heterogeneity in etiology and co-occurring difficulties among youth presenting with depression symptoms. This and a companion paper (Lewandowski et al., 2022) draw on a recent multisite collaboration that focused on implementing depression treatment for adolescents within clinical and research contexts. Specifically, this paper will review our work adapting behavioral activation (BA) as a principle-based framework to improve effectiveness and efficiency of depression treatment used within clinical and research settings in academic medical centers. Piloted adaptations include the use of BA principles to address idiographic drivers of depression and in-session BA "exposures" to illustrate BA principles. Case vignettes illustrate these adaptations of BA to address adolescent depression in the context of co-occurring difficulties.
SCOPUS:85126202065
ISSN: 2379-4925
CID: 5189142

Trends in ASD Pharmacological Research: An Analysis of ClinicalTrials.gov

Cervantes, Paige E.; Conlon, Greta R.; Shalev, Rebecca A.; Castellanos, F. Xavier
Despite decades of research, both understanding and availability of pharmacological interventions for autistic people are limited. We examined characteristics of pharmacological trials on ClinicalTrials.gov (N = 235) to elucidate trends, identify gaps, and suggest future research directions. We observed that trials predominantly sampled school-aged children and adolescents and focused largely on core autism symptoms, neglecting younger children and adults as well as associated symptom domains often identified by stakeholders as treatment priorities. A variety of intervention agents were trialed, with nearly 60% appearing in just one study. Notably, in line with previous research, there was little consistency in outcome measures used, with the majority (58.9%) used in only one trial. Innovation in research strategies is urgently needed; potential directions for such changes are discussed.
SCOPUS:85122512584
ISSN: 2195-7177
CID: 5145062

Be a person

Chapter by: Cox, Lara Jo; Marsh, Akeem Nassor
in: Not Just Bad Kids: The Adversity and Disruptive Behavior Link by
[S.l.] : Elsevier, 2022
pp. 601-641
ISBN: 9780128189542
CID: 5199342

Implementing a Child Mental Health Intervention in Child Welfare Services: Stakeholder Perspectives on Feasibility

Gopalan, Geetha; Lee, Kerry A.; Pisciotta, Caterina; Hooley, Cole; Stephens, Tricia; Acri, Mary
This pilot study integrated quantitative and qualitative data to examine the feasibility of implementing a modified version of a multiple family group behavioral parent training intervention (The 4Rs and 2Ss for Strengthening Families Program [4Rs and 2Ss]) in child welfare (CW) placement prevention services from the perspectives of participating caregivers (n = 12) and CW staff (n = 12; i.e., 6 caseworkers, 4 supervisors, and 2 administrators). Quantitative surveys were administered to caregivers and CW staff followed by semi-structured interviews to examine the feasibility of implementing the modified 4Rs and 2Ss program as well as factors impacting feasibility. Results indicated that quantitative benchmarks for high feasibility were met in all assessed areas (e.g., family recruitment, caseworker fidelity ratings, CW staff feasibility ratings) except for family attendance, which was markedly lower than desired. Factors facilitating feasibility included agency and research support, intervention ease-of-use, perceived benefits to existing CW practice, and logistical support (e.g., food, transportation, child care) promoting attendance. Factors hindering feasibility included conflicts between research-based eligibility criteria and existing client population demographics, research-related processes resulting in delays, CW staff role conflicts, added workload burden, complex family issues, and power differentials inherent to CW services which complicated families"™ voluntary participation.
SCOPUS:85138413009
ISSN: 1063-4266
CID: 5331242

Kids grown up

Chapter by: Marsh, Gayla E.; Marsh, Akeem Nassor; Cox, Lara Jo; Linick, Jessica; Dallara-Marsh, Alexis
in: Not Just Bad Kids: The Adversity and Disruptive Behavior Link by
[S.l.] : Elsevier, 2022
pp. 487-509
ISBN: 9780128189542
CID: 5199142